Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat

By Berdeu D.   Gross R.   Puech R.   Loubatieres-Mariani M.-M.   Bertrand G.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 91-98

Elsevier

Access to resources Recommend Favorite

Blockade by agmatine of catecholamine release from chromaffin cells is unrelated to imidazoline receptors

By Santos W.C.   Hernandez-Guijo J.M.   Ruiz-Nuno A.   Olivares R.   Jurkiewicz A.   Ganda L.   Garca A.G.  

European Journal of Pharmacology, Vol. 417, Iss. 1, 2001-04 ,pp. : 99-109

Elsevier

Access to resources Recommend Favorite

Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca 2+ -dependent exocytosis in pancreatic - and -cells

By Hoy M.   Olsen H.L.   Andersen H.S.   Bokvist K.   Buschard K.   Hansen J.   Jacobsen P.   Petersen J.S.   Rorsman P.   Gromada J.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite

The effect of agmatine on the vascular reactivity in streptozotocin-diabetic rats

By Ozyazgan S.   Bicakci B.   Ozaydin A.   Denizbasi A.   Unluer E.E.   Akkan A.G.  

Pharmacological Research, Vol. 48, Iss. 2, 2003-08 ,pp. : 133-138

Elsevier

Access to resources Recommend Favorite

Imidazoline binding sites in Huntington's and Parkinson's disease putamen

By Reynolds G.P.   Boulton R.M.   Pearson S.J.   Hudson A.L.   Nutt D.J.  

European Journal of Pharmacology, Vol. 301, Iss. 1, 1996-04 ,pp. : 19-21

Elsevier

Access to resources Recommend Favorite